SEC Form 4 · accession 0001493152-17-010977
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Early
Officer — Chief Financial Officer
Period of report
Sep 26, 2017
Accepted (ET)
Sep 27, 2017 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.45 | Sep 26, 2017 | A | 40,000 | A | — | Sep 26, 2018 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The stock option award vests and becomes exercisable over a period of one year in twelve equal installments, commencing on the 15th day of each calendar month, subject to the reporting person's continued service with the issuer.